You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The virus, known as HPgV-2, was detected in blood samples from individuals with concurrent hepatitis C virus infections.
A team of Chinese researchers has found using PCR and sequencing approaches that avian flu appears to have been transmitted between two unrelated people.
A survey of small mammals from around the world uncovered new and known hepatoviruses that are helping to clarify relationships between viral clades.
An analysis of angiosarcoma-derived cell lines identified a NUP160-SLC43A3 fusion that subsequently turned up in aggressive primary tumor samples.
New research suggests Ebola virus may appear in survivor sperm samples some nine months after disease onset, though sexual transmission appears relatively rare.
A National Institutes of Health team demonstrated EBOV RNA can be found in semen using strategies approved for finding the virus in blood.
The first tranche of the targeted $20 million financing round will be used to accelerate adoption of the company's melanoma test.
A new study has found that an antigen-based rapid diagnostic test for Ebola could be more reliable under certain circumstances than a recently approved RT-PCR assay for the virus.
Clinicians at the recent ASCO noted that more practical and accurate molecular diagnostics are approaching the clinic alongside novel targeted drug regimens.
Authors of the Ontario study said that their survey suggests the need for clinical guidelines to standardize use of the test among oncologists and for resources to improve patients' understanding of results.
Public health experts call for a transparent COVID-19 vaccine approval process in a letter; the Food and Drug Administration commissioner assures science-based approval.
The Verge reports that new gene-naming guidelines aim in part to avoid Excel-related name change confusion.
In Nature this week: tuatara genome sequence aids in understanding amniote evolution, and more.
According to the Guardian, UK virologists say in a letter to officials that their expertise has been pushed aside in COVID-19 response plans.